News | Radiation Oncology | May 18, 2021

Comprehensive approach to complex cases enables broad access to exceptional medical expertise from world-renowned specialists at Cleveland Clinic

The Clinic by Cleveland Clinic, a transformative joint venture between Cleveland Clinic and Amwell that aligns world-class clinical expertise with the power of innovative digital health technologies, announced that its virtual second opinion solution, available to health plans, employers and consumers, will now include multidisciplinary case analysis.

May 18, 2021 — The Clinic by Cleveland Clinic, a transformative joint venture between Cleveland Clinic and Amwell that aligns world-class clinical expertise with the power of innovative digital health technologies, announced that its virtual second opinion solution, available to health plans, employers and consumers, will now include multidisciplinary case analysis. The Clinic’s virtual second opinion offering provides patients, including those with complex medical conditions, the ability to obtain support from Cleveland Clinic’s world-renowned multidisciplinary panels, whose diversity of expertise ensures the most comprehensive and coordinated second opinion and treatment plan is offered.

“We chose to enter into the multi-disciplinary opinion space by offering services for brain tumor and prostate cancers because there are multiple treatment options for these patients,” said Peter Rasmussen, M.D., Chief Clinical Officer with The Clinic. “Given that these cancers can be treated with surgery, chemotherapeutics, and/or several different types of radiation, one physician isn't able to deliver a holistic opinion. Only multiple physicians from multiple specialties can provide the best recommendation to yield the highest quality of care and thereby the best value care. Our goal is to give patients access to Cleveland Clinic’s vast medical expertise from a variety of different perspectives for the best patient outcomes.”

According to a study published by the National Institutes of Health, more than 40% of cancer patients seeking a second opinion had a change in diagnosis as a result of multidisciplinary panel review, while 23% of patients were determined to present with additional, previously-undiagnosed cancers.

Added Frank McGillin, CEO of The Clinic, “Pairing patients who have complex medical conditions with coordinated support for multidisciplinary review reduces the risk of suboptimal treatment plans. It also protects them from higher-than-necessary healthcare expenses while providing peace of mind that they’re on the right path. For employers and health plans, the right diagnosis and treatment equates to better member outcomes and reduced costs of care.”

For more information: www.theclinic.io


Related Content

News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group—lead by authors at the University of Toronto—have developed an approach for ...

Time April 23, 2024
arrow
News | FDA

April 23, 2024 — Royal Philips , a global leader in health technology, today announced its Philips Zenition 30 mobile C ...

Time April 23, 2024
arrow
News | Ultrasound Imaging

April 22, 2024 — GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which ...

Time April 22, 2024
arrow
News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | ACR

April 15, 2023 — The American College of Radiology (ACR) released an update to its ACR Appropriateness Criteria (ACR AC) ...

Time April 13, 2024
arrow
Subscribe Now